	US 12,485,095 B2
	Plurality of tasquinimod particles and use thereof
Hans Wännman, Ängelholm (SE)
Assigned to ACTIVE BIOTECH AB, Lund (SE)
Appl. No. 18/289,738
Filed by ACTIVE BIOTECH AB, Lund (SE)
PCT Filed May 23, 2022, PCT No. PCT/EP2022/063887 § 371(c)(1), (2) Date Nov. 6, 2023, PCT Pub. No. WO2022/248401, PCT Pub. Date Dec. 1, 2022.
Claims priority of application No. 21175623 (EP), filed on May 25, 2021.
Prior Publication US 2024/0285532 A1, Aug. 29, 2024
Int. Cl. A61K 9/14 (2006.01); A61K 31/4704 (2006.01)

CPC A61K 9/14 (2013.01) [A61K 31/4704 (2013.01)]

17 Claims

1. A plurality of particles comprising tasquinimod in free base form or as a pharmaceutically acceptable salt, said particles having a D (v,0.9) of at most 30 μm and a D (v,0.5) of at most 15 μm.